Immunohistochemistry for ALK protein expression has been available for many years for use in the diagnosis of anaplastic large-cell lymphoma, but the traditional antibodies for use in lymphoma are insufficiently sensitive for detection at the level at which it is expressed in ALK-rearranged lung cancers. This evidence concerns the gene ALK and lung cancer.